Arthur Levin
Director/Board Member presso AVIDITY BIOSCIENCES, INC.
Patrimonio netto: 7 M $ in data 31/03/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Troy Wilson | M | 55 | 12 anni | |
| Edward Kaye | M | 74 | 7 anni | |
| Sarah Boyce | F | 52 | 5 anni | |
| Seth Harrison | M | 63 | 9 anni | |
| Kathleen Gallagher | F | - | 3 anni | |
| Adrian Krainer | M | 65 | 10 anni | |
| Huw Nash | M | 57 | 10 anni | |
| Eric B. Mosbrooker | M | 46 | 3 anni | |
| John W. Wallen | M | 66 | 12 anni | |
| Carsten Boess | M | 57 | 4 anni | |
| Jennifer Burstein | F | 52 | 5 anni | |
| Tamar Thompson | F | 50 | 3 anni | |
| Isabel Aznarez | M | 52 | 10 anni | |
| Noreen Henig | M | 59 | 5 anni | |
| Arthur Tzianabos | M | 60 | 6 anni | |
| Jonathan Allan | M | - | - | |
| Jean J. Kim | F | 50 | 3 anni | |
| Ian Smith | M | 58 | 1 anni | |
| Julie Smith | F | 53 | 4 anni | |
| Garry Menzel | M | 59 | 4 anni | |
| Michael MacLean | M | 58 | 4 anni | |
| Doug Snow | M | - | 3 anni | |
| Teresa McCarthy | F | 60 | 4 anni | |
| Domenico Valerio | M | 67 |
Amylon Therapeutics BV
 Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Amylon Therapeutics BV is a biopharmaceutical company, which engages in the research and development of therapies for the central nervous system. It specializes in ribonucleic acid modulation technology to target rare genetic disorders. The company was founded by Thomas de Vlaam and is headquartered in Leiden, the Netherlands. | 7 anni |
| Barry Ticho | M | 64 | 7 anni | |
| Steven G. Hughes | M | 57 | 2 anni | |
| Stephen Tulipano | M | 65 | 5 anni | |
| Bo Jesper Hansen | M | 66 |
Amylon Therapeutics BV
Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Amylon Therapeutics BV is a biopharmaceutical company, which engages in the research and development of therapies for the central nervous system. It specializes in ribonucleic acid modulation technology to target rare genetic disorders. The company was founded by Thomas de Vlaam and is headquartered in Leiden, the Netherlands. | - |
| Eric Rojas | M | - | - | |
| Shamim Ruff | F | 64 | 6 anni | |
| Joan Wood | F | - | 5 anni | |
| W. Flanagan | M | 62 | 3 anni | |
| Dawn Kalmar | F | 47 | 5 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Michael Martin | M | 50 | 5 anni | |
| Robin A. Walker | M | 55 | 1 anni | |
| Peter Hawryluk | M | 55 | 7 anni | |
| Christopher J. Morl | M | 65 |
miRagen Therapeutics, Inc. /Old/
 miRagen Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology miRagen Therapeutics, Inc. develops microRNA-based therapeutics for cardiovascular and muscle diseases. It leverages in-house expertise in miRNA biology, oligonucleotide chemistry, and drug development to evaluate and advance RNA-based technologies and potential drug candidates for its own pipeline and in strategic collaborations. The firm aso focuses on hematological malignancies, fibrosis and neuro inflammation. The company was founded by William S. Marshall, Michael R. Bristow, Marvin H. Caruthers, Bruce Lee Booth and Eric Newell Olson in 2007 and is headquartered in Boulder, CO. | 3 anni |
| Rod Wong | M | 47 | 2 anni | |
| Todd Brady | M | 45 | 5 anni | |
| Nancy M. Wyant | F | - | 5 anni | |
| Steve Bajan | M | - |
Muhlenberg College
| 4 anni |
| Meena | M | 51 | 4 anni | |
| Charles R. Allerson | M | 56 | 2 anni | |
| Gene Liau | M | 69 | 4 anni | |
| Martin Brenner | M | 54 | 1 anni | |
| Jae B. Kim | M | 55 | 1 anni | |
| Andrew J. Geall | M | - | - | |
| Tony Hsu | M | - | - | |
| Aimee L. Jackson | M | - |
miRagen Therapeutics, Inc. /Old/
miRagen Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology miRagen Therapeutics, Inc. develops microRNA-based therapeutics for cardiovascular and muscle diseases. It leverages in-house expertise in miRNA biology, oligonucleotide chemistry, and drug development to evaluate and advance RNA-based technologies and potential drug candidates for its own pipeline and in strategic collaborations. The firm aso focuses on hematological malignancies, fibrosis and neuro inflammation. The company was founded by William S. Marshall, Michael R. Bristow, Marvin H. Caruthers, Bruce Lee Booth and Eric Newell Olson in 2007 and is headquartered in Boulder, CO. | - |
| Mitchell Eisenberg | M | - |
Muhlenberg College
| 4 anni |
| Orin Levy | M | - |
Muhlenberg College
| 3 anni |
| Daniel Fisher | M | 67 |
Muhlenberg College
| 4 anni |
| Raymond Schilling | M | - |
Muhlenberg College
| 4 anni |
| Jeffrey Goodman | M | 68 |
Muhlenberg College
| 4 anni |
| Richard A. Mitstifer | M | 66 |
Muhlenberg College
| 4 anni |
| Sam Hall | M | 42 | 5 anni | |
| Michael Pocalyko | M | 69 |
Muhlenberg College
| 4 anni |
| Sarah G. Avery | F | - |
Muhlenberg College
| 4 anni |
| Karl Bourdeau | M | - |
Muhlenberg College
| 4 anni |
| Richard Frederick Brueckner | M | 74 |
Muhlenberg College
| 4 anni |
| Terence S. Novak | M | 67 |
Muhlenberg College
| 4 anni |
| Joseph Baroldi | M | 46 | 2 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 60 | 96.77% |
| Paesi Bassi | 2 | 3.23% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Arthur Levin
- Contatti personali
